市場調査レポート
商品コード
1500826

臨床検査の世界市場:規模、シェア、動向分析レポート(用途別、技術別、地域別展望と予測、2024年-2031年)

Global Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Application, By Technology, By Regional Outlook and Forecast, 2024 - 2031

出版日: | 発行: KBV Research | ページ情報: 英文 282 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
臨床検査の世界市場:規模、シェア、動向分析レポート(用途別、技術別、地域別展望と予測、2024年-2031年)
出版日: 2024年06月21日
発行: KBV Research
ページ情報: 英文 282 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床検査市場規模は、予測期間中に6.9%のCAGRで市場成長し、2031年までに203億米ドルに達すると予想されています。

パンデミックは世界のサプライチェーンを混乱させ、臨床検査の開発と検査に必要な試薬、消耗品、機器の入手性に影響を与えました。研究室は必須材料の調達に課題に直面し、検査の開発と実施の遅れにつながりました。しかし、パンデミックは診断検査の緊急のニーズを満たすために、臨床検査を含むCOVID-19検査の開発と展開を加速させました。したがって、 COVID-19パンデミックは市場に中程度の影響を及ぼしました。

しかし、マルチモーダルテストでは、包括的な診断情報を提供するために、ゲノミクス、プロテオミクス、メタボロミクス、イメージングなどの複数のテストモダリティを統合することがよくあります。さらに、マルチモーダルテストでは、ゲノム配列、タンパク質発現プロファイル、代謝経路、イメージングスキャンなど、複数のソースから大量の異種データが生成されます。そのため、マルチモーダルテストの複雑さが市場の成長を妨げています。

用途別展望

用途別に基づいて、市場は腫瘍学、遺伝性疾患/遺伝性疾患、感染症および寄生虫病、免疫学、内分泌、栄養および代謝疾患、心臓病学、精神/行動障害、小児科特有の検査、その他に分類されます。感染症および寄生虫病セグメントは、2023年に市場で14%の収益シェアを獲得しました。感染症および寄生虫病の臨床検査には、細菌、ウイルス、真菌、寄生虫など、さまざまな病原体を検出および識別するように設計された幅広い検査が含まれます。

技術別展望

技術に基づいて、市場は免疫測定、血液学および凝固、分子診断、微生物学、臨床化学、組織学/細胞学、フローサイトメトリー、質量分析、その他に分類されます。免疫測定セグメントは、2023年に市場で19.9%の収益シェアを獲得しました。免疫測定は高い感度と特異性を提供し、低濃度でもバイオマーカーの正確な検出と定量化を可能にします。この機能は、病状の早期診断、病気の進行の監視、治療効果の評価、再発の検出に不可欠です。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカにわたって分析されています。2023年には、北米地域が市場で38%の収益シェアを記録しました。この地域は、特に分子診断、ゲノミクス、個別化医療の分野における技術革新の世界的リーダーです。技術の進歩により、次世代シーケンシング、PCRベースのアッセイ、マイクロアレイ技術、デジタル病理学システムを活用した洗練された臨床検査の開発が可能になります。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場の課題
  • ポーターのファイブフォース分析

第4章 ラボ開発テスト市場で展開される戦略。

第5章 世界の臨床検査市場:用途別

  • 世界の腫瘍学市場:地域別
  • 世界の遺伝性疾患/遺伝性疾患市場:地域別
  • 世界の感染症および寄生虫病市場:地域別
  • 世界の内分泌市場:地域別
  • 世界の免疫学市場:地域別
  • 世界の栄養・代謝疾患市場:地域別
  • 世界の心臓病市場:地域別
  • 世界の精神・行動障害市場:地域別
  • 世界の小児科専門検査市場:地域別
  • 世界のその他の市場:地域別

第6章 世界の臨床検査市場:技術別

  • 世界の分子診断市場:地域別
  • 世界の免疫測定市場:地域別
  • 世界の血液学および凝固市場:地域別
  • 世界の微生物学市場:地域別
  • 世界の臨床化学市場:地域別
  • 世界の組織学/細胞学市場:地域別
  • 世界のフローサイトメトリー市場:地域別
  • 世界の質量分析市場:地域別
  • 世界のその他の市場:地域別

第7章 世界の臨床検査市場:地域別

  • 北米
    • 北米の臨床検査市場:国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の臨床検査市場:国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋地域
    • アジア太平洋の臨床検査市場:国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの臨床検査市場:国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第8章 企業プロファイル

  • Neogenomics, Inc
  • Guardant Health, Inc
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Siemens Healthineers AG(Siemens AG)
  • Illumina, Inc
  • Bio-Rad laboratories, Inc
  • F Hoffmann-La Roche Ltd.
  • Eurofins Scientific SE

第9章 ラボ開発検査市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 2 Global Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 3 Global Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 4 Global Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 5 Global Oncology Market by Region, 2020 - 2023, USD Million
  • TABLE 6 Global Oncology Market by Region, 2024 - 2031, USD Million
  • TABLE 7 Global Genetic Disorders/Inherited Disease Market by Region, 2020 - 2023, USD Million
  • TABLE 8 Global Genetic Disorders/Inherited Disease Market by Region, 2024 - 2031, USD Million
  • TABLE 9 Global Infectious & Parasitic Diseases Market by Region, 2020 - 2023, USD Million
  • TABLE 10 Global Infectious & Parasitic Diseases Market by Region, 2024 - 2031, USD Million
  • TABLE 11 Global Endocrine Market by Region, 2020 - 2023, USD Million
  • TABLE 12 Global Endocrine Market by Region, 2024 - 2031, USD Million
  • TABLE 13 Global Immunology Market by Region, 2020 - 2023, USD Million
  • TABLE 14 Global Immunology Market by Region, 2024 - 2031, USD Million
  • TABLE 15 Global Nutritional & Metabolic Disease Market by Region, 2020 - 2023, USD Million
  • TABLE 16 Global Nutritional & Metabolic Disease Market by Region, 2024 - 2031, USD Million
  • TABLE 17 Global Cardiology Market by Region, 2020 - 2023, USD Million
  • TABLE 18 Global Cardiology Market by Region, 2024 - 2031, USD Million
  • TABLE 19 Global Mental/Behavioral Disorder Market by Region, 2020 - 2023, USD Million
  • TABLE 20 Global Mental/Behavioral Disorder Market by Region, 2024 - 2031, USD Million
  • TABLE 21 Global Pediatrics-specific Testing Market by Region, 2020 - 2023, USD Million
  • TABLE 22 Global Pediatrics-specific Testing Market by Region, 2024 - 2031, USD Million
  • TABLE 23 Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 24 Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 25 Global Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 26 Global Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 27 Global Molecular Diagnostics Market by Region, 2020 - 2023, USD Million
  • TABLE 28 Global Molecular Diagnostics Market by Region, 2024 - 2031, USD Million
  • TABLE 29 Global Immunoassays Market by Region, 2020 - 2023, USD Million
  • TABLE 30 Global Immunoassays Market by Region, 2024 - 2031, USD Million
  • TABLE 31 Global Hematology & Coagulation Market by Region, 2020 - 2023, USD Million
  • TABLE 32 Global Hematology & Coagulation Market by Region, 2024 - 2031, USD Million
  • TABLE 33 Global Microbiology Market by Region, 2020 - 2023, USD Million
  • TABLE 34 Global Microbiology Market by Region, 2024 - 2031, USD Million
  • TABLE 35 Global Clinical Chemistry Market by Region, 2020 - 2023, USD Million
  • TABLE 36 Global Clinical Chemistry Market by Region, 2024 - 2031, USD Million
  • TABLE 37 Global Histology/Cytology Market by Region, 2020 - 2023, USD Million
  • TABLE 38 Global Histology/Cytology Market by Region, 2024 - 2031, USD Million
  • TABLE 39 Global Flow Cytometry Market by Region, 2020 - 2023, USD Million
  • TABLE 40 Global Flow Cytometry Market by Region, 2024 - 2031, USD Million
  • TABLE 41 Global Mass Spectroscopy Market by Region, 2020 - 2023, USD Million
  • TABLE 42 Global Mass Spectroscopy Market by Region, 2024 - 2031, USD Million
  • TABLE 43 Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 44 Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 45 Global Laboratory Developed Tests Market by Region, 2020 - 2023, USD Million
  • TABLE 46 Global Laboratory Developed Tests Market by Region, 2024 - 2031, USD Million
  • TABLE 47 North America Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 48 North America Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 49 North America Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 50 North America Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 51 North America Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 52 North America Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 53 North America Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 54 North America Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 55 North America Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 56 North America Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 57 North America Endocrine Market by Country, 2020 - 2023, USD Million
  • TABLE 58 North America Endocrine Market by Country, 2024 - 2031, USD Million
  • TABLE 59 North America Immunology Market by Country, 2020 - 2023, USD Million
  • TABLE 60 North America Immunology Market by Country, 2024 - 2031, USD Million
  • TABLE 61 North America Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 62 North America Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 63 North America Cardiology Market by Country, 2020 - 2023, USD Million
  • TABLE 64 North America Cardiology Market by Country, 2024 - 2031, USD Million
  • TABLE 65 North America Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
  • TABLE 66 North America Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
  • TABLE 67 North America Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 68 North America Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 69 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 70 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 71 North America Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 72 North America Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 73 North America Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 74 North America Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 75 North America Immunoassays Market by Country, 2020 - 2023, USD Million
  • TABLE 76 North America Immunoassays Market by Country, 2024 - 2031, USD Million
  • TABLE 77 North America Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
  • TABLE 78 North America Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
  • TABLE 79 North America Microbiology Market by Country, 2020 - 2023, USD Million
  • TABLE 80 North America Microbiology Market by Country, 2024 - 2031, USD Million
  • TABLE 81 North America Clinical Chemistry Market by Country, 2020 - 2023, USD Million
  • TABLE 82 North America Clinical Chemistry Market by Country, 2024 - 2031, USD Million
  • TABLE 83 North America Histology/Cytology Market by Country, 2020 - 2023, USD Million
  • TABLE 84 North America Histology/Cytology Market by Country, 2024 - 2031, USD Million
  • TABLE 85 North America Flow Cytometry Market by Country, 2020 - 2023, USD Million
  • TABLE 86 North America Flow Cytometry Market by Country, 2024 - 2031, USD Million
  • TABLE 87 North America Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
  • TABLE 88 North America Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
  • TABLE 89 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 90 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 91 North America Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 92 North America Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 93 US Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 94 US Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 95 US Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 96 US Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 97 US Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 98 US Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 99 Canada Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 100 Canada Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 101 Canada Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 102 Canada Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 103 Canada Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 104 Canada Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 105 Mexico Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 106 Mexico Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 107 Mexico Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 108 Mexico Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 109 Mexico Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 110 Mexico Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 111 Rest of North America Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 112 Rest of North America Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 113 Rest of North America Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 114 Rest of North America Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 115 Rest of North America Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 116 Rest of North America Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 117 Europe Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 118 Europe Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 119 Europe Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 120 Europe Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 121 Europe Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 122 Europe Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 123 Europe Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 124 Europe Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 125 Europe Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 126 Europe Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 127 Europe Endocrine Market by Country, 2020 - 2023, USD Million
  • TABLE 128 Europe Endocrine Market by Country, 2024 - 2031, USD Million
  • TABLE 129 Europe Immunology Market by Country, 2020 - 2023, USD Million
  • TABLE 130 Europe Immunology Market by Country, 2024 - 2031, USD Million
  • TABLE 131 Europe Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 132 Europe Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 133 Europe Cardiology Market by Country, 2020 - 2023, USD Million
  • TABLE 134 Europe Cardiology Market by Country, 2024 - 2031, USD Million
  • TABLE 135 Europe Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
  • TABLE 136 Europe Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
  • TABLE 137 Europe Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 138 Europe Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 139 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 140 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 141 Europe Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 142 Europe Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 143 Europe Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 144 Europe Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 145 Europe Immunoassays Market by Country, 2020 - 2023, USD Million
  • TABLE 146 Europe Immunoassays Market by Country, 2024 - 2031, USD Million
  • TABLE 147 Europe Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
  • TABLE 148 Europe Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
  • TABLE 149 Europe Microbiology Market by Country, 2020 - 2023, USD Million
  • TABLE 150 Europe Microbiology Market by Country, 2024 - 2031, USD Million
  • TABLE 151 Europe Clinical Chemistry Market by Country, 2020 - 2023, USD Million
  • TABLE 152 Europe Clinical Chemistry Market by Country, 2024 - 2031, USD Million
  • TABLE 153 Europe Histology/Cytology Market by Country, 2020 - 2023, USD Million
  • TABLE 154 Europe Histology/Cytology Market by Country, 2024 - 2031, USD Million
  • TABLE 155 Europe Flow Cytometry Market by Country, 2020 - 2023, USD Million
  • TABLE 156 Europe Flow Cytometry Market by Country, 2024 - 2031, USD Million
  • TABLE 157 Europe Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
  • TABLE 158 Europe Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
  • TABLE 159 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 160 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 161 Europe Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 162 Europe Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 163 Germany Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 164 Germany Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 165 Germany Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 166 Germany Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 167 Germany Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 168 Germany Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 169 UK Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 170 UK Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 171 UK Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 172 UK Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 173 UK Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 174 UK Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 175 France Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 176 France Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 177 France Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 178 France Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 179 France Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 180 France Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 181 Russia Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 182 Russia Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 183 Russia Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 184 Russia Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 185 Russia Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 186 Russia Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 187 Spain Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 188 Spain Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 189 Spain Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 190 Spain Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 191 Spain Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 192 Spain Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 193 Italy Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 194 Italy Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 195 Italy Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 196 Italy Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 197 Italy Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 198 Italy Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 199 Rest of Europe Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 200 Rest of Europe Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 201 Rest of Europe Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 202 Rest of Europe Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 203 Rest of Europe Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 204 Rest of Europe Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 205 Asia Pacific Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 206 Asia Pacific Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 207 Asia Pacific Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 208 Asia Pacific Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 209 Asia Pacific Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 210 Asia Pacific Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 211 Asia Pacific Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 212 Asia Pacific Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 213 Asia Pacific Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 214 Asia Pacific Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 215 Asia Pacific Endocrine Market by Country, 2020 - 2023, USD Million
  • TABLE 216 Asia Pacific Endocrine Market by Country, 2024 - 2031, USD Million
  • TABLE 217 Asia Pacific Immunology Market by Country, 2020 - 2023, USD Million
  • TABLE 218 Asia Pacific Immunology Market by Country, 2024 - 2031, USD Million
  • TABLE 219 Asia Pacific Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 220 Asia Pacific Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 221 Asia Pacific Cardiology Market by Country, 2020 - 2023, USD Million
  • TABLE 222 Asia Pacific Cardiology Market by Country, 2024 - 2031, USD Million
  • TABLE 223 Asia Pacific Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
  • TABLE 224 Asia Pacific Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
  • TABLE 225 Asia Pacific Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 226 Asia Pacific Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 227 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 228 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 229 Asia Pacific Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 230 Asia Pacific Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 231 Asia Pacific Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 232 Asia Pacific Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 233 Asia Pacific Immunoassays Market by Country, 2020 - 2023, USD Million
  • TABLE 234 Asia Pacific Immunoassays Market by Country, 2024 - 2031, USD Million
  • TABLE 235 Asia Pacific Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
  • TABLE 236 Asia Pacific Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
  • TABLE 237 Asia Pacific Microbiology Market by Country, 2020 - 2023, USD Million
  • TABLE 238 Asia Pacific Microbiology Market by Country, 2024 - 2031, USD Million
  • TABLE 239 Asia Pacific Clinical Chemistry Market by Country, 2020 - 2023, USD Million
  • TABLE 240 Asia Pacific Clinical Chemistry Market by Country, 2024 - 2031, USD Million
  • TABLE 241 Asia Pacific Histology/Cytology Market by Country, 2020 - 2023, USD Million
  • TABLE 242 Asia Pacific Histology/Cytology Market by Country, 2024 - 2031, USD Million
  • TABLE 243 Asia Pacific Flow Cytometry Market by Country, 2020 - 2023, USD Million
  • TABLE 244 Asia Pacific Flow Cytometry Market by Country, 2024 - 2031, USD Million
  • TABLE 245 Asia Pacific Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
  • TABLE 246 Asia Pacific Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
  • TABLE 247 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 248 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 249 Asia Pacific Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 250 Asia Pacific Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 251 China Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 252 China Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 253 China Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 254 China Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 255 China Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 256 China Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 257 Japan Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 258 Japan Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 259 Japan Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 260 Japan Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 261 Japan Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 262 Japan Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 263 India Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 264 India Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 265 India Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 266 India Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 267 India Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 268 India Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 269 South Korea Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 270 South Korea Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 271 South Korea Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 272 South Korea Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 273 South Korea Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 274 South Korea Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 275 Singapore Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 276 Singapore Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 277 Singapore Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 278 Singapore Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 279 Singapore Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 280 Singapore Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 281 Malaysia Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 282 Malaysia Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 283 Malaysia Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 284 Malaysia Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 285 Malaysia Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 286 Malaysia Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 287 Rest of Asia Pacific Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 288 Rest of Asia Pacific Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 289 Rest of Asia Pacific Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 290 Rest of Asia Pacific Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 291 Rest of Asia Pacific Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 292 Rest of Asia Pacific Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 293 LAMEA Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 294 LAMEA Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 295 LAMEA Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 296 LAMEA Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 297 LAMEA Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 298 LAMEA Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 299 LAMEA Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 300 LAMEA Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 301 LAMEA Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 302 LAMEA Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 303 LAMEA Endocrine Market by Country, 2020 - 2023, USD Million
  • TABLE 304 LAMEA Endocrine Market by Country, 2024 - 2031, USD Million
  • TABLE 305 LAMEA Immunology Market by Country, 2020 - 2023, USD Million
  • TABLE 306 LAMEA Immunology Market by Country, 2024 - 2031, USD Million
  • TABLE 307 LAMEA Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 308 LAMEA Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 309 LAMEA Cardiology Market by Country, 2020 - 2023, USD Million
  • TABLE 310 LAMEA Cardiology Market by Country, 2024 - 2031, USD Million
  • TABLE 311 LAMEA Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
  • TABLE 312 LAMEA Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
  • TABLE 313 LAMEA Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 314 LAMEA Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 315 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 316 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 317 LAMEA Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 318 LAMEA Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 319 LAMEA Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 320 LAMEA Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 321 LAMEA Immunoassays Market by Country, 2020 - 2023, USD Million
  • TABLE 322 LAMEA Immunoassays Market by Country, 2024 - 2031, USD Million
  • TABLE 323 LAMEA Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
  • TABLE 324 LAMEA Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
  • TABLE 325 LAMEA Microbiology Market by Country, 2020 - 2023, USD Million
  • TABLE 326 LAMEA Microbiology Market by Country, 2024 - 2031, USD Million
  • TABLE 327 LAMEA Clinical Chemistry Market by Country, 2020 - 2023, USD Million
  • TABLE 328 LAMEA Clinical Chemistry Market by Country, 2024 - 2031, USD Million
  • TABLE 329 LAMEA Histology/Cytology Market by Country, 2020 - 2023, USD Million
  • TABLE 330 LAMEA Histology/Cytology Market by Country, 2024 - 2031, USD Million
  • TABLE 331 LAMEA Flow Cytometry Market by Country, 2020 - 2023, USD Million
  • TABLE 332 LAMEA Flow Cytometry Market by Country, 2024 - 2031, USD Million
  • TABLE 333 LAMEA Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
  • TABLE 334 LAMEA Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
  • TABLE 335 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 336 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 337 LAMEA Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
  • TABLE 338 LAMEA Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
  • TABLE 339 Brazil Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 340 Brazil Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 341 Brazil Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 342 Brazil Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 343 Brazil Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 344 Brazil Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 345 Argentina Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 346 Argentina Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 347 Argentina Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 348 Argentina Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 349 Argentina Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 350 Argentina Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 351 UAE Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 352 UAE Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 353 UAE Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 354 UAE Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 355 UAE Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 356 UAE Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 357 Saudi Arabia Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 358 Saudi Arabia Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 359 Saudi Arabia Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 360 Saudi Arabia Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 361 Saudi Arabia Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 362 Saudi Arabia Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 363 South Africa Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 364 South Africa Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 365 South Africa Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 366 South Africa Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 367 South Africa Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 368 South Africa Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 369 Nigeria Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 370 Nigeria Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 371 Nigeria Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 372 Nigeria Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 373 Nigeria Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 374 Nigeria Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 375 Rest of LAMEA Laboratory Developed Tests Market, 2020 - 2023, USD Million
  • TABLE 376 Rest of LAMEA Laboratory Developed Tests Market, 2024 - 2031, USD Million
  • TABLE 377 Rest of LAMEA Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
  • TABLE 378 Rest of LAMEA Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
  • TABLE 379 Rest of LAMEA Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
  • TABLE 380 Rest of LAMEA Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
  • TABLE 381 Key Information - neogenomics, inc.
  • TABLE 382 Key Information - GUARDANT HEALTH, INC.
  • TABLE 383 Key Information - Qiagen N.V.
  • TABLE 384 Key information - Quest Diagnostics Incorporated
  • TABLE 385 Key Information - Abbott Laboratories
  • TABLE 386 Key Information - Siemens Healthineers AG
  • TABLE 387 key information - Illumina, Inc.
  • TABLE 388 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 389 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 390 Key Information - Eurofins Scientific SE
目次

The Global Laboratory Developed Tests Market size is expected to reach $20.3 billion by 2031, rising at a market growth of 6.9% CAGR during the forecast period.

LDTs encompass a wide range of genetic tests designed to diagnose various types of inherited diseases, including single-gene disorders, chromosomal abnormalities, mitochondrial disorders, and complex genetic conditions. Consequently, the genetic disorders/ inherited disease segment would acquire nearly 10% of the total market share by 2031. These tests can identify disease-causing mutations in genes associated with conditions such as cystic fibrosis, muscular dystrophy, inherited cancers, and rare genetic syndromes.

As healthcare expenditure rises, there is often a corresponding increase in demand for advanced diagnostic tests. In addition, with greater investment in healthcare, there's usually more funding available for research and development of new diagnostic technologies. Hence, increasing healthcare expenditure is driving the growth of the market. Additionally, POCT enables rapid testing and decision-making at or near the point of patient care, leading to quicker diagnosis and treatment initiation. Moreover, POCT facilitates rapid and on-demand testing, which aligns with personalized medicine principles. Hence, the expansion of point-of-care testing drives the market's growth.

The pandemic disrupted global supply chains, affecting the availability of reagents, consumables, and equipment necessary for LDT development and testing. Laboratories faced challenges in sourcing essential materials, leading to test development and implementation delays. However, the pandemic accelerated the development and deployment of COVID-19 tests, including LDTs, to meet the urgent need for diagnostic testing. Thus, the COVID-19 pandemic had a moderate impact on the market.

However, Multimodal testing often involves integrating multiple testing modalities, such as genomics, proteomics, metabolomics, and imaging, to provide comprehensive diagnostic information. Furthermore, multimodal testing generates large volumes of heterogeneous data from multiple sources, including genomic sequences, protein expression profiles, metabolic pathways, and imaging scans. Therefore, the complexity of multimodal testing is hampering the market's growth.

Application Outlook

On the basis of application, the market is segmented into oncology, genetic disorders/inherited disease, infectious & parasitic diseases, immunology, endocrine, nutritional & metabolic disease, cardiology, mental/behavioral disorder, pediatrics-specific testing, and others. The infectious & parasitic diseases segment attained a 14% revenue share in the market in 2023. LDTs for infectious and parasitic diseases encompass a wide range of tests designed to detect and identify various pathogens, including bacteria, viruses, fungi, and parasites.

Technology Outlook

Based on technology, the market is divided into immunoassays, hematology & coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy, and others. The immunoassays segment attained 19.9% revenue share in the market in 2023. Immunoassays offer high sensitivity and specificity, allowing for accurate detection and quantification of biomarkers even at low concentrations. This capability is crucial for diagnosing conditions early, monitoring disease progression, evaluating treatment efficacy, and detecting relapse or recurrence.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the North America region witnessed 38% revenue share in the market. The region is a global leader in technological innovation, particularly in the fields of molecular diagnostics, genomics, and personalized medicine. Technological advancements enable the development of sophisticated LDTs that utilize next-generation sequencing, PCR-based assays, microarray technologies, and digital pathology systems.

Recent Strategies Deployed in the Market

  • May-2024: Quest Diagnostics Incorporated took over PathAI Diagnostics, a leading laboratory services company based in Memphis, TN. Through this acquisition, Quest Diagnostics would expedite the uptake of digital and AI pathology advancements for enhancing the quality, speed, and efficiency of diagnosing cancer and other illnesses.
  • Feb-2024: Abbott Laboratories came into partnership with Fujirebio, a Japanese multinational biotechnology company. Through this partnership, Abbott Laboratories would create a research-only neurofilament-light chain (Nf-L) neurology biomarker assay for use with Abbott's Alinity(R) i.
  • Jan-2024: Neogenomics, Inc. came into partnership with ConcertAI LLC, a biotechnology research company. Through this partnership, Neogenomics, Inc. would advance broad-scale hematological research solutions for exploring real-world clinical practices and outcomes in hematological malignancies.
  • Jan-2023: Qiagen N.V introduced "EZ2 Connect MDx" for use in diagnostic laboratories. EZ2 Connect MDx brings standardized and efficient nucleic acid purification within reach of any clinical laboratory, paired with the QIAsphere digital system enabling remote instrument management.
  • Jul-2022: Guardant Health, Inc. came into partnership with Adicon Holdings Limited, a leading independent clinical laboratory company based in China. Through this partnership, Guardant Health, Inc. would provide biopharmaceutical companies conducting clinical trials in China with Guardant Health's comprehensive genomic profiling (CGP) tests.

List of Key Companies Profiled

  • Neogenomics, Inc.
  • Guardant Health, Inc.
  • Qiagen N.V
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Siemens Healthineers AG (Siemens AG)
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eurofins Scientific SE

Global Laboratory Developed Tests Market Report Segmentation

By Application

  • Oncology
  • Genetic Disorders/Inherited Disease
  • Infectious & Parasitic Diseases
  • Endocrine
  • Immunology
  • Nutritional & Metabolic Disease
  • Cardiology
  • Mental/Behavioral Disorder
  • Pediatrics-specific Testing
  • Others

By Technology

  • Molecular Diagnostics
  • Immunoassays
  • Hematology & Coagulation
  • Microbiology
  • Clinical Chemistry
  • Histology/Cytology
  • Flow Cytometry
  • Mass Spectroscopy
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Laboratory Developed Tests Market, by Application
    • 1.4.2 Global Laboratory Developed Tests Market, by Technology
    • 1.4.3 Global Laboratory Developed Tests Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.

Chapter 5. Global Laboratory Developed Tests Market by Application

  • 5.1 Global Oncology Market by Region
  • 5.2 Global Genetic Disorders/Inherited Disease Market by Region
  • 5.3 Global Infectious & Parasitic Diseases Market by Region
  • 5.4 Global Endocrine Market by Region
  • 5.5 Global Immunology Market by Region
  • 5.6 Global Nutritional & Metabolic Disease Market by Region
  • 5.7 Global Cardiology Market by Region
  • 5.8 Global Mental/Behavioral Disorder Market by Region
  • 5.9 Global Pediatrics-specific Testing Market by Region
  • 5.1 Global Others Market by Region

Chapter 6. Global Laboratory Developed Tests Market by Technology

  • 6.1 Global Molecular Diagnostics Market by Region
  • 6.2 Global Immunoassays Market by Region
  • 6.3 Global Hematology & Coagulation Market by Region
  • 6.4 Global Microbiology Market by Region
  • 6.5 Global Clinical Chemistry Market by Region
  • 6.6 Global Histology/Cytology Market by Region
  • 6.7 Global Flow Cytometry Market by Region
  • 6.8 Global Mass Spectroscopy Market by Region
  • 6.9 Global Others Market by Region

Chapter 7. Global Laboratory Developed Tests Market by Region

  • 7.1 North America Laboratory Developed Tests Market
    • 7.1.1 North America Laboratory Developed Tests Market by Application
      • 7.1.1.1 North America Oncology Market by Country
      • 7.1.1.2 North America Genetic Disorders/Inherited Disease Market by Country
      • 7.1.1.3 North America Infectious & Parasitic Diseases Market by Country
      • 7.1.1.4 North America Endocrine Market by Country
      • 7.1.1.5 North America Immunology Market by Country
      • 7.1.1.6 North America Nutritional & Metabolic Disease Market by Country
      • 7.1.1.7 North America Cardiology Market by Country
      • 7.1.1.8 North America Mental/Behavioral Disorder Market by Country
      • 7.1.1.9 North America Pediatrics-specific Testing Market by Country
      • 7.1.1.10 North America Others Market by Country
    • 7.1.2 North America Laboratory Developed Tests Market by Technology
      • 7.1.2.1 North America Molecular Diagnostics Market by Country
      • 7.1.2.2 North America Immunoassays Market by Country
      • 7.1.2.3 North America Hematology & Coagulation Market by Country
      • 7.1.2.4 North America Microbiology Market by Country
      • 7.1.2.5 North America Clinical Chemistry Market by Country
      • 7.1.2.6 North America Histology/Cytology Market by Country
      • 7.1.2.7 North America Flow Cytometry Market by Country
      • 7.1.2.8 North America Mass Spectroscopy Market by Country
      • 7.1.2.9 North America Others Market by Country
    • 7.1.3 North America Laboratory Developed Tests Market by Country
      • 7.1.3.1 US Laboratory Developed Tests Market
        • 7.1.3.1.1 US Laboratory Developed Tests Market by Application
        • 7.1.3.1.2 US Laboratory Developed Tests Market by Technology
      • 7.1.3.2 Canada Laboratory Developed Tests Market
        • 7.1.3.2.1 Canada Laboratory Developed Tests Market by Application
        • 7.1.3.2.2 Canada Laboratory Developed Tests Market by Technology
      • 7.1.3.3 Mexico Laboratory Developed Tests Market
        • 7.1.3.3.1 Mexico Laboratory Developed Tests Market by Application
        • 7.1.3.3.2 Mexico Laboratory Developed Tests Market by Technology
      • 7.1.3.4 Rest of North America Laboratory Developed Tests Market
        • 7.1.3.4.1 Rest of North America Laboratory Developed Tests Market by Application
        • 7.1.3.4.2 Rest of North America Laboratory Developed Tests Market by Technology
  • 7.2 Europe Laboratory Developed Tests Market
    • 7.2.1 Europe Laboratory Developed Tests Market by Application
      • 7.2.1.1 Europe Oncology Market by Country
      • 7.2.1.2 Europe Genetic Disorders/Inherited Disease Market by Country
      • 7.2.1.3 Europe Infectious & Parasitic Diseases Market by Country
      • 7.2.1.4 Europe Endocrine Market by Country
      • 7.2.1.5 Europe Immunology Market by Country
      • 7.2.1.6 Europe Nutritional & Metabolic Disease Market by Country
      • 7.2.1.7 Europe Cardiology Market by Country
      • 7.2.1.8 Europe Mental/Behavioral Disorder Market by Country
      • 7.2.1.9 Europe Pediatrics-specific Testing Market by Country
      • 7.2.1.10 Europe Others Market by Country
    • 7.2.2 Europe Laboratory Developed Tests Market by Technology
      • 7.2.2.1 Europe Molecular Diagnostics Market by Country
      • 7.2.2.2 Europe Immunoassays Market by Country
      • 7.2.2.3 Europe Hematology & Coagulation Market by Country
      • 7.2.2.4 Europe Microbiology Market by Country
      • 7.2.2.5 Europe Clinical Chemistry Market by Country
      • 7.2.2.6 Europe Histology/Cytology Market by Country
      • 7.2.2.7 Europe Flow Cytometry Market by Country
      • 7.2.2.8 Europe Mass Spectroscopy Market by Country
      • 7.2.2.9 Europe Others Market by Country
    • 7.2.3 Europe Laboratory Developed Tests Market by Country
      • 7.2.3.1 Germany Laboratory Developed Tests Market
        • 7.2.3.1.1 Germany Laboratory Developed Tests Market by Application
        • 7.2.3.1.2 Germany Laboratory Developed Tests Market by Technology
      • 7.2.3.2 UK Laboratory Developed Tests Market
        • 7.2.3.2.1 UK Laboratory Developed Tests Market by Application
        • 7.2.3.2.2 UK Laboratory Developed Tests Market by Technology
      • 7.2.3.3 France Laboratory Developed Tests Market
        • 7.2.3.3.1 France Laboratory Developed Tests Market by Application
        • 7.2.3.3.2 France Laboratory Developed Tests Market by Technology
      • 7.2.3.4 Russia Laboratory Developed Tests Market
        • 7.2.3.4.1 Russia Laboratory Developed Tests Market by Application
        • 7.2.3.4.2 Russia Laboratory Developed Tests Market by Technology
      • 7.2.3.5 Spain Laboratory Developed Tests Market
        • 7.2.3.5.1 Spain Laboratory Developed Tests Market by Application
        • 7.2.3.5.2 Spain Laboratory Developed Tests Market by Technology
      • 7.2.3.6 Italy Laboratory Developed Tests Market
        • 7.2.3.6.1 Italy Laboratory Developed Tests Market by Application
        • 7.2.3.6.2 Italy Laboratory Developed Tests Market by Technology
      • 7.2.3.7 Rest of Europe Laboratory Developed Tests Market
        • 7.2.3.7.1 Rest of Europe Laboratory Developed Tests Market by Application
        • 7.2.3.7.2 Rest of Europe Laboratory Developed Tests Market by Technology
  • 7.3 Asia Pacific Laboratory Developed Tests Market
    • 7.3.1 Asia Pacific Laboratory Developed Tests Market by Application
      • 7.3.1.1 Asia Pacific Oncology Market by Country
      • 7.3.1.2 Asia Pacific Genetic Disorders/Inherited Disease Market by Country
      • 7.3.1.3 Asia Pacific Infectious & Parasitic Diseases Market by Country
      • 7.3.1.4 Asia Pacific Endocrine Market by Country
      • 7.3.1.5 Asia Pacific Immunology Market by Country
      • 7.3.1.6 Asia Pacific Nutritional & Metabolic Disease Market by Country
      • 7.3.1.7 Asia Pacific Cardiology Market by Country
      • 7.3.1.8 Asia Pacific Mental/Behavioral Disorder Market by Country
      • 7.3.1.9 Asia Pacific Pediatrics-specific Testing Market by Country
      • 7.3.1.10 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Laboratory Developed Tests Market by Technology
      • 7.3.2.1 Asia Pacific Molecular Diagnostics Market by Country
      • 7.3.2.2 Asia Pacific Immunoassays Market by Country
      • 7.3.2.3 Asia Pacific Hematology & Coagulation Market by Country
      • 7.3.2.4 Asia Pacific Microbiology Market by Country
      • 7.3.2.5 Asia Pacific Clinical Chemistry Market by Country
      • 7.3.2.6 Asia Pacific Histology/Cytology Market by Country
      • 7.3.2.7 Asia Pacific Flow Cytometry Market by Country
      • 7.3.2.8 Asia Pacific Mass Spectroscopy Market by Country
      • 7.3.2.9 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Laboratory Developed Tests Market by Country
      • 7.3.3.1 China Laboratory Developed Tests Market
        • 7.3.3.1.1 China Laboratory Developed Tests Market by Application
        • 7.3.3.1.2 China Laboratory Developed Tests Market by Technology
      • 7.3.3.2 Japan Laboratory Developed Tests Market
        • 7.3.3.2.1 Japan Laboratory Developed Tests Market by Application
        • 7.3.3.2.2 Japan Laboratory Developed Tests Market by Technology
      • 7.3.3.3 India Laboratory Developed Tests Market
        • 7.3.3.3.1 India Laboratory Developed Tests Market by Application
        • 7.3.3.3.2 India Laboratory Developed Tests Market by Technology
      • 7.3.3.4 South Korea Laboratory Developed Tests Market
        • 7.3.3.4.1 South Korea Laboratory Developed Tests Market by Application
        • 7.3.3.4.2 South Korea Laboratory Developed Tests Market by Technology
      • 7.3.3.5 Singapore Laboratory Developed Tests Market
        • 7.3.3.5.1 Singapore Laboratory Developed Tests Market by Application
        • 7.3.3.5.2 Singapore Laboratory Developed Tests Market by Technology
      • 7.3.3.6 Malaysia Laboratory Developed Tests Market
        • 7.3.3.6.1 Malaysia Laboratory Developed Tests Market by Application
        • 7.3.3.6.2 Malaysia Laboratory Developed Tests Market by Technology
      • 7.3.3.7 Rest of Asia Pacific Laboratory Developed Tests Market
        • 7.3.3.7.1 Rest of Asia Pacific Laboratory Developed Tests Market by Application
        • 7.3.3.7.2 Rest of Asia Pacific Laboratory Developed Tests Market by Technology
  • 7.4 LAMEA Laboratory Developed Tests Market
    • 7.4.1 LAMEA Laboratory Developed Tests Market by Application
      • 7.4.1.1 LAMEA Oncology Market by Country
      • 7.4.1.2 LAMEA Genetic Disorders/Inherited Disease Market by Country
      • 7.4.1.3 LAMEA Infectious & Parasitic Diseases Market by Country
      • 7.4.1.4 LAMEA Endocrine Market by Country
      • 7.4.1.5 LAMEA Immunology Market by Country
      • 7.4.1.6 LAMEA Nutritional & Metabolic Disease Market by Country
      • 7.4.1.7 LAMEA Cardiology Market by Country
      • 7.4.1.8 LAMEA Mental/Behavioral Disorder Market by Country
      • 7.4.1.9 LAMEA Pediatrics-specific Testing Market by Country
      • 7.4.1.10 LAMEA Others Market by Country
    • 7.4.2 LAMEA Laboratory Developed Tests Market by Technology
      • 7.4.2.1 LAMEA Molecular Diagnostics Market by Country
      • 7.4.2.2 LAMEA Immunoassays Market by Country
      • 7.4.2.3 LAMEA Hematology & Coagulation Market by Country
      • 7.4.2.4 LAMEA Microbiology Market by Country
      • 7.4.2.5 LAMEA Clinical Chemistry Market by Country
      • 7.4.2.6 LAMEA Histology/Cytology Market by Country
      • 7.4.2.7 LAMEA Flow Cytometry Market by Country
      • 7.4.2.8 LAMEA Mass Spectroscopy Market by Country
      • 7.4.2.9 LAMEA Others Market by Country
    • 7.4.3 LAMEA Laboratory Developed Tests Market by Country
      • 7.4.3.1 Brazil Laboratory Developed Tests Market
        • 7.4.3.1.1 Brazil Laboratory Developed Tests Market by Application
        • 7.4.3.1.2 Brazil Laboratory Developed Tests Market by Technology
      • 7.4.3.2 Argentina Laboratory Developed Tests Market
        • 7.4.3.2.1 Argentina Laboratory Developed Tests Market by Application
        • 7.4.3.2.2 Argentina Laboratory Developed Tests Market by Technology
      • 7.4.3.3 UAE Laboratory Developed Tests Market
        • 7.4.3.3.1 UAE Laboratory Developed Tests Market by Application
        • 7.4.3.3.2 UAE Laboratory Developed Tests Market by Technology
      • 7.4.3.4 Saudi Arabia Laboratory Developed Tests Market
        • 7.4.3.4.1 Saudi Arabia Laboratory Developed Tests Market by Application
        • 7.4.3.4.2 Saudi Arabia Laboratory Developed Tests Market by Technology
      • 7.4.3.5 South Africa Laboratory Developed Tests Market
        • 7.4.3.5.1 South Africa Laboratory Developed Tests Market by Application
        • 7.4.3.5.2 South Africa Laboratory Developed Tests Market by Technology
      • 7.4.3.6 Nigeria Laboratory Developed Tests Market
        • 7.4.3.6.1 Nigeria Laboratory Developed Tests Market by Application
        • 7.4.3.6.2 Nigeria Laboratory Developed Tests Market by Technology
      • 7.4.3.7 Rest of LAMEA Laboratory Developed Tests Market
        • 7.4.3.7.1 Rest of LAMEA Laboratory Developed Tests Market by Application
        • 7.4.3.7.2 Rest of LAMEA Laboratory Developed Tests Market by Technology

Chapter 8. Company Profiles

  • 8.1 Neogenomics, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
    • 8.1.6 SWOT Analysis
  • 8.2 Guardant Health, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Research & Development Expenses
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
    • 8.2.6 SWOT Analysis
  • 8.3 Qiagen N.V.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Product Launches and Product Expansions:
      • 8.3.5.3 Acquisition and Mergers:
    • 8.3.6 SWOT Analysis
  • 8.4 Quest Diagnostics Incorporated
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental Analysis
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Acquisition and Mergers:
    • 8.4.5 SWOT Analysis
  • 8.5 Abbott Laboratories
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
    • 8.5.6 SWOT Analysis
  • 8.6 Siemens Healthineers AG (Siemens AG)
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
    • 8.6.6 SWOT Analysis
  • 8.7 Illumina, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segment and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Bio-Rad laboratories, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
    • 8.8.6 SWOT Analysis
  • 8.9 F. Hoffmann-La Roche Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
    • 8.9.5 SWOT Analysis
  • 8.10. Eurofins Scientific SE
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 SWOT Analysis

Chapter 9. Winning Imperatives of Laboratory Developed Tests Market